The statistical evidence in this study leads to the conclusion that the GEF TRIO may be particularly useful as a prognostic factor in breast cancer as its level is significantly increased in tumour tissue with Tiam-1 showing a significant increase in tumour tissue from patients with poor prognosis. Here, TRIO is linked to neoplasm.